These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3212157)

  • 21. Movement disorders.
    Cardoso F; Jankovic J
    Neurol Clin; 1993 Aug; 11(3):625-38. PubMed ID: 8377747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible cholinergic mechanism in reserpine and tardive dyskinesia.
    Dilsaver SC; Greden JF
    Am J Psychiatry; 1984 Jan; 141(1):151-2. PubMed ID: 6691448
    [No Abstract]   [Full Text] [Related]  

  • 23. [Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
    Horikawa H; Konagaya M; Mano Y; Takayanagi T
    Rinsho Shinkeigaku; 1985 Jun; 25(6):653-8. PubMed ID: 4053459
    [No Abstract]   [Full Text] [Related]  

  • 24. Associated medical disorders and disabilities in children with autistic disorder: a population-based study.
    Kielinen M; Rantala H; Timonen E; Linna SL; Moilanen I
    Autism; 2004 Mar; 8(1):49-60. PubMed ID: 15070547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing akathisia and tardive dyskinesia: a review of the literature.
    Munetz MR; Cornes CL
    J Clin Psychopharmacol; 1983 Dec; 3(6):343-50. PubMed ID: 6139392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Movements in autistic disorder.
    Brasić JR
    Med Hypotheses; 1999 Jul; 53(1):48-9. PubMed ID: 10499825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent parkinsonism and tardive dyskinesia induced by clebopride.
    Jiménez-Jiménez FJ; Cabrera-Valdivia F; Ayuso-Peralta L; Tejeiro J; Vaquero A; García-Albea E
    Mov Disord; 1993 Apr; 8(2):246-7. PubMed ID: 8474508
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kanner's syndrome of early infantile autism].
    Bashina VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(10):1538-42. PubMed ID: 4432715
    [No Abstract]   [Full Text] [Related]  

  • 32. What may be gained from neuropsychological investigations of tardive dyskinesia?
    Cohen H; Cohen D
    Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
    Ferentinos P; Christodoulou C; Rizos E; Douzenis A; Lykouras L
    J Clin Psychopharmacol; 2010 Oct; 30(5):644-6. PubMed ID: 20841971
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistent dyskinesia and obsessive-compulsive behavior following alcohol withdrawal.
    Cardoso F; Vargas AP
    Neurology; 1996 Sep; 47(3):844. PubMed ID: 8797494
    [No Abstract]   [Full Text] [Related]  

  • 35. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Crit Care Med; 2008 Aug; 36(8):2427-32. PubMed ID: 18596622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tardive dyskinesia: a review].
    Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA; Costa G; Bond G; Abu-Elmagd KM
    Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central determinants of attention and mood disorder in tardive dyskinesia ("tardive dysmentia").
    Myslobodsky MS
    Brain Cogn; 1993 Sep; 23(1):88-101. PubMed ID: 8217124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Movement disorders in the elderly.
    Gilmore R
    Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615
    [No Abstract]   [Full Text] [Related]  

  • 40. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.